nipradilol has been researched along with Myopia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nowroozzadeh, MH | 1 |
| Araie, M; Kitazawa, Y; Matsumoto, C; Ohashi, Y; Shirato, S; Yamazaki, Y | 1 |
| Aizawa, D; Igarashi, A; Kamiya, K; Komatsu, M; Shimizu, K | 1 |
| Mokhtarzadeh, M; Weiss, JS | 1 |
2 trial(s) available for nipradilol and Myopia
| Article | Year |
|---|---|
Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy.
Topics: Adrenergic beta-Antagonists; Disease Progression; Double-Blind Method; Female; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Myopia; Ophthalmic Solutions; Prognosis; Propanolamines; Prospective Studies; Risk Factors; Timolol; Tonometry, Ocular; Vision Disorders; Visual Fields | 2012 |
Effects of antiglaucoma drugs on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Astigmatism; Cornea; Female; Humans; Intraocular Pressure; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Myopia; Ophthalmic Solutions; Postoperative Complications; Propanolamines; Prospective Studies; Refraction, Ocular; Visual Acuity | 2008 |
2 other study(ies) available for nipradilol and Myopia
| Article | Year |
|---|---|
Prostaglandin analogs may aggravate myopic regression after laser in situ keratomileusis.
Topics: Administration, Topical; Antihypertensive Agents; Cornea; Humans; Intraocular Pressure; Keratomileusis, Laser In Situ; Lasers, Excimer; Myopia; Ophthalmic Solutions; Postoperative Complications; Propanolamines; Prostaglandins F, Synthetic; Refraction, Ocular; Visual Acuity | 2009 |
Myopic regression after laser in situ keratomileusis: a medical alternative to surgical enhancement.
Topics: Adrenergic beta-Antagonists; Cornea; Humans; Intraocular Pressure; Keratomileusis, Laser In Situ; Lasers, Excimer; Myopia; Ophthalmic Solutions; Postoperative Complications; Propanolamines | 2008 |